The association between TET2 (Tet Methylcytosine Dioxygenase 2) and Myelodysplastic Syndrome is well established and manually curated, with its 3 contributing sources — 2 of them expert-curated — recording a known molecular basis and likely-pathogenic variants.
Sources3
Clinical variants9
Symptoms1
Compounds1
Trials243of 712 via TET2 compounds
Publications0
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.